Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson's disease management in developing countries. (2nd June 2020)
- Record Type:
- Journal Article
- Title:
- Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson's disease management in developing countries. (2nd June 2020)
- Main Title:
- Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson's disease management in developing countries
- Authors:
- Bhidayasiri, Roongroj
Phokaewvarangkul, Onanong
Sakdisornchai, Karn
Boonpang, Kamolwan
Chaudhuri, K. Ray
Parsons, Jan
Lolekha, Praween
Chairangsaris, Parnsiri
Srivanitchapoom, Prachaya
Benedierks, Sharon
Panyakaew, Pattamon
Boonmongkol, Thanatat
Thongchuam, Yuwadee
Kantachadvanich, Nitinan
Phumphid, Saisamorn
Evans, Andrew H.
Viriyavejakul, Akravudh
Pisarnpong, Apichart
van Laar, Teus
Jagota, Priya - Abstract:
- ABSTRACT: Introduction: The increasing global burden of Parkinson's disease (PD) poses a particular challenge for developing countries, such as Thailand, when delivering care to a geographically diverse populace with limited resources, often compounded by a lack of expertise in the use of certain PD medications, such as device-aided therapies (DAT). Areas covered: A panel of local, regional, and international PD experts convened to review the unmet needs of PD in Thailand and share insights into effective delivery of DAT, focusing on experience with apomorphine infusion. Despite its proven efficacy and safety, implementation of apomorphine infusion as a new option was not straightforward. This has prompted a range of health-care professional and patient-focused initiatives, led by the Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders in Bangkok, to help establish a more coordinated approach to PD management throughout the country and ensure patients have access to suitable treatments. Expert opinion: Overcoming the challenges of education, proficiency, resource capacity and standard of care for PD patients in developing countries requires a coordinated effort both nationally and beyond. The best practices identified in Thailand following the introduction of apomorphine infusion might be helpful for other countries when implementing similar programs.
- Is Part Of:
- Expert review of neurotherapeutics. Volume 20:Number 6(2020)
- Journal:
- Expert review of neurotherapeutics
- Issue:
- Volume 20:Number 6(2020)
- Issue Display:
- Volume 20, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 20
- Issue:
- 6
- Issue Sort Value:
- 2020-0020-0006-0000
- Page Start:
- 523
- Page End:
- 537
- Publication Date:
- 2020-06-02
- Subjects:
- Parkinson's disease -- apomorphine infusion -- motor complications -- Thailand -- developing countries -- device-aided therapy -- Parkinson's disease nurse specialists -- treatment accessibility -- specialist centers
Neuropharmacology -- Periodicals
615.7805 - Journal URLs:
- http://www.expert-reviews.com/loi/ern ↗
http://www.future-drugs.com/loi/ern ↗
http://www.tandfonline.com/toc/iern20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14737175.2020.1770598 ↗
- Languages:
- English
- ISSNs:
- 1473-7175
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002995
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 22641.xml